BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11070026)

  • 21. Cotranscriptional Chromatin Remodeling by Small RNA Species: An HTLV-1 Perspective.
    Aliya N; Rahman S; Khan ZK; Jain P
    Leuk Res Treatment; 2012; 2012():984754. PubMed ID: 23213554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the Genetic Organization, Expression Strategies and Oncogenic Potential of HTLV-1 and HTLV-2.
    Rende F; Cavallari I; Romanelli MG; Diani E; Bertazzoni U; Ciminale V
    Leuk Res Treatment; 2012; 2012():876153. PubMed ID: 23213551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Converging strategies in expression of human complex retroviruses.
    Cavallari I; Rende F; D'Agostino DM; Ciminale V
    Viruses; 2011 Aug; 3(8):1395-414. PubMed ID: 21994786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular determinants of human T-lymphotropic virus type 1 transmission and spread.
    Lairmore MD; Anupam R; Bowden N; Haines R; Haynes RA; Ratner L; Green PL
    Viruses; 2011 Jul; 3(7):1131-65. PubMed ID: 21994774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Orf-I and orf-II-encoded proteins in HTLV-1 infection and persistence.
    Edwards D; Fenizia C; Gold H; de Castro-Amarante MF; Buchmann C; Pise-Masison CA; Franchini G
    Viruses; 2011 Jun; 3(6):861-85. PubMed ID: 21994758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human T Lymphotropic Virus Type 1 (HTLV-1): Molecular Biology and Oncogenesis.
    Kannian P; Green PL
    Viruses; 2010 Sep; 2(9):2037-2077. PubMed ID: 21994719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppression of HTLV-1 replication by Tax-mediated rerouting of the p13 viral protein to nuclear speckles.
    Andresen V; Pise-Masison CA; Sinha-Datta U; Bellon M; Valeri V; Washington Parks R; Cecchinato V; Fukumoto R; Nicot C; Franchini G
    Blood; 2011 Aug; 118(6):1549-59. PubMed ID: 21677314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human T-lymphotropic virus type 1 p30 interacts with REGgamma and modulates ATM (ataxia telangiectasia mutated) to promote cell survival.
    Anupam R; Datta A; Kesic M; Green-Church K; Shkriabai N; Kvaratskhelia M; Lairmore MD
    J Biol Chem; 2011 Mar; 286(9):7661-8. PubMed ID: 21216954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HTLV-I p30 inhibits multiple S phase entry checkpoints, decreases cyclin E-CDK2 interactions and delays cell cycle progression.
    Baydoun HH; Pancewicz J; Bai X; Nicot C
    Mol Cancer; 2010 Nov; 9():302. PubMed ID: 21092281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Requirement of the human T-cell leukemia virus p12 and p30 products for infectivity of human dendritic cells and macaques but not rabbits.
    Valeri VW; Hryniewicz A; Andresen V; Jones K; Fenizia C; Bialuk I; Chung HK; Fukumoto R; Parks RW; Ferrari MG; Nicot C; Cecchinato V; Ruscetti F; Franchini G
    Blood; 2010 Nov; 116(19):3809-17. PubMed ID: 20647569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genome wide analysis of human genes transcriptionally and post-transcriptionally regulated by the HTLV-I protein p30.
    Taylor JM; Ghorbel S; Nicot C
    BMC Genomics; 2009 Jul; 10():311. PubMed ID: 19602286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcriptional control of spliced and unspliced human T-cell leukemia virus type 1 bZIP factor (HBZ) gene.
    Yoshida M; Satou Y; Yasunaga J; Fujisawa J; Matsuoka M
    J Virol; 2008 Oct; 82(19):9359-68. PubMed ID: 18653454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human T-cell leukemia virus type 2 post-transcriptional control protein p28 is required for viral infectivity and persistence in vivo.
    Yamamoto B; Li M; Kesic M; Younis I; Lairmore MD; Green PL
    Retrovirology; 2008 May; 5():38. PubMed ID: 18474092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human T Lymphotropic Virus Type 1 protein Tax reduces histone levels.
    Bogenberger JM; Laybourn PJ
    Retrovirology; 2008 Jan; 5():9. PubMed ID: 18237376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular aspects of HTLV-I infection and adult T-cell leukaemia/lymphoma.
    Taylor G
    J Clin Pathol; 2007 Dec; 60(12):1392-6. PubMed ID: 18042695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human T-lymphotropic virus type-1 p30 alters cell cycle G2 regulation of T lymphocytes to enhance cell survival.
    Datta A; Silverman L; Phipps AJ; Hiraragi H; Ratner L; Lairmore MD
    Retrovirology; 2007 Jul; 4():49. PubMed ID: 17634129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection and quantitation of HTLV-1 and HTLV-2 mRNA species by real-time RT-PCR.
    Li M; Green PL
    J Virol Methods; 2007 Jun; 142(1-2):159-68. PubMed ID: 17337070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histone acetyltransferase (HAT) activity of p300 modulates human T lymphotropic virus type 1 p30II-mediated repression of LTR transcriptional activity.
    Michael B; Nair AM; Datta A; Hiraragi H; Ratner L; Lairmore MD
    Virology; 2006 Oct; 354(2):225-39. PubMed ID: 16890266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calcium-dependent enhancement of transcription of p300 by human T-lymphotropic type 1 p12I.
    Nair AM; Michael B; Datta A; Fernandez S; Lairmore MD
    Virology; 2006 Sep; 353(2):247-57. PubMed ID: 16843515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human T-lymphotropic virus type 1 mitochondrion-localizing protein p13(II) is required for viral infectivity in vivo.
    Hiraragi H; Kim SJ; Phipps AJ; Silic-Benussi M; Ciminale V; Ratner L; Green PL; Lairmore MD
    J Virol; 2006 Apr; 80(7):3469-76. PubMed ID: 16537614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.